WebApr 10, 2024 · Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes brain health medicines. Its product candidates include ZULRESSO, a CIV injection for the treatment of postpartum depression (PPD) in adults; zuranolone, a neuroactive steroid, which has completed Phase III clinical trials for treating PPD and … WebOn 1 February 2024, she was appointed as a Non-Executive Director of EKF Diagnostics Holdings plc, an AIM listed point-of-care, central lab devices and chemistry reagents business. Jennifer has a BSc in Physiology and Pharmacology from the University of Southampton. She was a Non-Executive Director of Allied Irish Bank from 2004 to 2010, …
An Educational Intervention Incorporating Digital Storytelling to ...
WebMar 16, 2024 · “We are thrilled to have Jessica join our Board of Directors. Jessica is a champion for patients and has a track record of innovation in data and digital … WebMar 16, 2024 · Sage Therapeutics, a biopharmaceutical company leading the way to create a world with better brain health, today announced the appointment of Jessica Federer to … sewing credit card holder pattern
Asylum Support Jobs in High Heaton - 2024 Indeed.com
WebMy key achievements in this role include • Developed Dashboard to help Health boards manage the prescribing of Inhaler, to help drive down the indicative carbon footprint related to the use of Inhalers. This has involved presenting to Welsh Government and Health boards. • Develop new measures to take into account deprivation. This involved … WebSage Therapeutics’s CEO is Barry Greene, appointed in Dec 2024, he has a tenure of 2.3yrs. His total yearly compensation is US$58.9m, comprised of 1.2% salary and 98.8% bonuses, … WebMar 16, 2024 · Published: Mar 16, 2024. CAMBRIDGE, Mass.-- ( BUSINESS WIRE )-- Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to … the truist